Influenza News and Research

Latest Influenza News and Research

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

U.S. government's draft guidance on funding for H5N1 research receives 'mixed reception,' Science reports

"Researchers are giving a mixed reception to a draft U.S. government plan to do more stringent funding reviews of certain kinds of H5N1 avian influenza research -- and perhaps even require some studies to be kept secret," Science reports.

8 Dec 2012

Research Roundup: Medicare Advantage Plan beneficiaries may get more appropriate use of services; CHIP participation grows; College students' flu vaccination rates weak

Analysis Of Medicare Advantage HMOs Compared With Traditional Medicare Shows Lower Use of Many Services During 2003-09 – Researchers compared the utilization rates of Medicare Advantage health maintenance organizations (HMOs) with those of traditional Medicare beneficiaries, 2003-09, "to ascertain whether the HMO enrollees demonstrated different levels of use of services, which can be a hallmark of more integrated care."

7 Dec 2012

Roundup: Florida health law battles take new turn; Oklahoma court rejects anti-abortion law; Calif. kids Medi-Cal dispute continues

Even in Florida, where Republican leaders led the legal battle against Obamacare, there's recognition now that the state has to act fast to comply with the new law. ... After Nov. 6, Gov. Rick Scott had a change in tone. "Gov. Mitt Romney did not win the election. So, it's not an option to repeal Obamacare," he said. "So, my goal now is to focus on what's good for our citizens." But Republicans are having trouble convincing Tea Party activists that the fight is over.

6 Dec 2012

Colleges and universities should implement new or improved flu vaccine strategies

College football and basketball games may provide more than a way for students to show school spirit - they could help prevent the flu.

3 Dec 2012

The Lancet issues special series of articles focused on emerging zoonoses

Today, the prestigious British medical journal, The Lancet, has issued a special series of articles focused on emerging zoonoses (human diseases that originate in or are shared with animals).

1 Dec 2012

Loss of either T-bet or Eomes protein reduces immune system's ability to fight viral infection

When you get an acute infection, such as influenza, the body generally responds with a coordinated response of immune-cell proliferation and attack that rapidly clears the pathogen. Then, their mission done, the immune system stands down, leaving a population of sentinel memory cells to rapidly redeploy the immune system in the event of reinfection.

1 Dec 2012

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria influenza vaccine to be delivered with the PharmaJet Stratis needle-free jet injector, as soon as the 2013-2014 flu season.

30 Nov 2012

Bend Research, PATH and FhCMB develop new technology for thermostable vaccine production

Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.

29 Nov 2012

SLU study to use various assays for new TB vaccine development

A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to address this global health crisis.

29 Nov 2012

Report finds decline in overall number and rate of healthcare-associated infections in Pennsylvania

The overall number and rate of healthcare-associated infections obtained while receiving medical care decreased more than 3 percent, according to an annual report released today by the Pennsylvania Department of Health.

29 Nov 2012

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

28 Nov 2012

Microneedle-based measles vaccine can immunize against measles

Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC).

28 Nov 2012

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

Scientists at Columbia University and the National Center for Atmospheric Research have adapted techniques used in modern weather prediction to generate local forecasts of seasonal influenza outbreaks.

28 Nov 2012

New system can predict timing and severity of seasonal influenza outbreaks

Scientists have developed a system to predict the timing and severity of seasonal influenza outbreaks that could one day help health officials and the general public better prepare for them. The system adapts techniques used in modern weather prediction to turn real-time, Web-based estimates of influenza infection into local forecasts of seasonal flu.

27 Nov 2012

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

"An experimental vaccine based on a molecule related to DNA protects animals against influenza and may one day offer an ultra-rapid way to develop new shots for humans, German scientists reported on Sunday," Reuters reports.

27 Nov 2012

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

Inovio Pharmaceuticals, Inc. announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV is also associated with numerous inflammatory diseases and cancers, and is implicated in hypertension, a major risk factor for cardiovascular diseases.

26 Nov 2012

mRNA vaccines offer protection against influenza A virus infections in various animal models

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.

26 Nov 2012

Major advance in understanding how flu viruses replicate within infected cells

Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to "see" one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.

23 Nov 2012

Online flu survey launched in the UK

Does “man flu” exist? How effective is the flu vaccine? And do pets keep you healthy? These are just some of the questions scientists from the London School of Hygiene & Tropical Medicine want to explore as they launch a nationwide flu survey.

22 Nov 2012

Influenza News and Research

Latest Influenza News and Research

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

U.S. government's draft guidance on funding for H5N1 research receives 'mixed reception,' Science reports

Research Roundup: Medicare Advantage Plan beneficiaries may get more appropriate use of services; CHIP participation grows; College students' flu vaccination rates weak

Roundup: Florida health law battles take new turn; Oklahoma court rejects anti-abortion law; Calif. kids Medi-Cal dispute continues

Colleges and universities should implement new or improved flu vaccine strategies

The Lancet issues special series of articles focused on emerging zoonoses

Loss of either T-bet or Eomes protein reduces immune system's ability to fight viral infection

CSL, PharmaJet partner for needle-free delivery of Afluria influenza vaccine

Bend Research, PATH and FhCMB develop new technology for thermostable vaccine production

SLU study to use various assays for new TB vaccine development

Report finds decline in overall number and rate of healthcare-associated infections in Pennsylvania

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Microneedle-based measles vaccine can immunize against measles

Scientists adapt modern weather prediction techniques to generate local flu outbreak forecasts

New system can predict timing and severity of seasonal influenza outbreaks

Experimental flu vaccine technique could reduce time needed to develop new shots for humans

Inovio's SynCon DNA vaccine effective at inducing CD8+ T cell responses specific to CMV

mRNA vaccines offer protection against influenza A virus infections in various animal models

Major advance in understanding how flu viruses replicate within infected cells

Online flu survey launched in the UK

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in